The Nasal Drug Delivery Market has demonstrated substantial growth, with an estimated value of USD 76.85 billion in 2023. Projections suggest a further increase, with expectations set to reach USD 137.06 billion by 2031. This growth reflects the growing demand for non-invasive drug delivery methods and the advantages offered by nasal drug delivery, such as rapid onset of action, improved bioavailability, and patient convenience. With an anticipated compound annual growth rate (CAGR) of approximately 7.5% over the forecast period from 2024 to 2031, the market is poised for significant expansion, presenting opportunities for innovation and development in drug delivery technologies and formulations tailored for nasal administration.